Brain Health Imaging Centre

What the facility does

Neuroimaging research on psychiatric and neurological disorders using Positron-Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) scanning

Areas of expertise

The Centre for Addiction and Mental Health (CAMH) Brain Health Imaging Centre is one of the few brain-imaging facilities that is fully dedicated to research on mental illness and addictions, offering both Positron-Emission Tomography (PET) and MRI imaging. In the past 20 years, CAMH PET research has yielded major discoveries that have been applied to clinical treatment and drug development and have led to the creation of widely used radiotracers.

Research services

Positron-Emission Tomography (PET) neuroimaging, Magnetic Resonance (MR) neuroimaging including Diffusion Tensor Imaging (DTI), Magnetic Resonance Spectroscopy (MRS) Imaging-genetics

Sectors of application

Healthcare and social services

Life sciences, pharmaceuticals and medical equipment

Specialized labs and equipment

Equipment	Function
Scanditronix MC-17F cyclotron
IBA Cyclone 18 twin high-current cyclotron
Two radiochemistry laboratories with 17 hot cells for radiosynthesis; quality-control laboratory	Radiosynthesis of Positron-Emission Tomography (PET) radiotracers for imaging and development of new PET probes for brain research
Siemens High-Resolution Research Tomograph (HRRT) scanner	Brain high-resolution PET imaging
Siemens Biograph-16 PET/CT scanner	Whole-body PET/CT imaging
GE MR750 3-Tesla MRI scanner	Anatomical, functional and spectroscopic imaging
Scansys carbon-11 carbon-monoxide modules	Automated radiosynthesis modules for radiopharmaceutical production for routine human use and applications, radiochemistry R&D and preclinical doses
GE TRACERlab FX_FN Pro modules	Automated radiosynthesis modules for radiopharmaceutical production for routine human use and applications, radiochemistry R&D and preclinical doses
Agilent High Performance Liquid Chromatography (HPLC) systems	Quality control of radiopharmaceuticals and the research and development of radiopharmaceutical compounds

Additional information

Title	URL
CAMH study reveals a new target for developing treatments for depression	http://www.camh.ca/en/camh-news-and-stories/camh-study-reveals-a-new-target-for-developing-treatments-for-depression
Hope for new moms	http://www.camh.ca/en/camh-news-and-stories/hope-for-new-moms
Stress affects people with schizophrenia differently, CAMH study shows	http://www.camh.ca/en/camh-news-and-stories/stress-affects-people-with-schizophrenia-differently-camh-study-shows
CAMH builds on radioimaging legacy with creation of the Azrieli Centre for Neuro-Radiochemistry	http://www.camh.ca/en/camh-news-and-stories/camh-builds-on-radioimaging-legacy-with-creation-of-the-azrieli-centre-for-neuro-radiochemistry